StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report issued on Friday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
CO opened at $1.50 on Friday. The stock has a market capitalization of $182.33 million, a price-to-earnings ratio of 2.34 and a beta of 0.16. The business has a 50-day moving average of $1.23 and a two-hundred day moving average of $1.35. Global Cord Blood has a 12 month low of $2.03 and a 12 month high of $5.50.
About Global Cord Blood
Read More
- Five stocks we like better than Global Cord Blood
- What is the NASDAQ Stock Exchange?
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- Bank Stocks – Best Bank Stocks to Invest In
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- What Makes a Stock a Good Dividend Stock?
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.